ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,097,275 | +13.7% | 513,525 | +1.9% | 0.64% | +12.4% |
| Q3 2022 | $9,760,000 | +5.5% | 504,138 | +8.2% | 0.57% | +26.6% |
| Q2 2022 | $9,251,000 | -34.7% | 465,804 | -1.9% | 0.45% | -20.9% |
| Q1 2022 | $14,169,000 | +32.8% | 474,991 | +3.7% | 0.56% | +49.1% |
| Q4 2021 | $10,667,000 | -32.7% | 458,011 | -9.8% | 0.38% | -35.2% |
| Q3 2021 | $15,840,000 | -11.8% | 507,681 | -0.5% | 0.58% | -8.5% |
| Q2 2021 | $17,958,000 | -11.1% | 510,467 | -10.9% | 0.64% | -2.9% |
| Q1 2021 | $20,195,000 | +109.2% | 572,899 | +122.6% | 0.66% | +93.5% |
| Q4 2020 | $9,654,000 | +231.2% | 257,372 | +194.6% | 0.34% | +190.6% |
| Q3 2020 | $2,915,000 | – | 87,358 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |